Qube Research & Technologies LTD Health Catalyst, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 282,281 shares of HCAT stock, worth $855,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
282,281
Previous 167,655
68.37%
Holding current value
$855,311
Previous $759,000
40.18%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HCAT
# of Institutions
153Shares Held
54.3MCall Options Held
20KPut Options Held
159K-
First Light Asset Management, LLC Edina, MN12.2MShares$37.1 Million7.09% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.18MShares$12.7 Million0.0% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.73MShares$11.3 Million5.13% of portfolio
-
Impax Asset Management Group PLC2.75MShares$8.33 Million0.07% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $166M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...